NeurologyLive Friday 5 — August 27, 2021

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Peer Exchange: Tailoring Therapy for Patients With Relapsing MS

In episode 2 of the NeurologyLive Peer Exchange, "Optimal Management of Relapsing Multiple Sclerosis: Advanced Practice Providers Perspectives," important insight related to individualized treatment approaches for patients with relapsing multiple sclerosis is offered by Amy Perrin Ross, APN, MSN, CNRN, MSCN; Stephanie Agrella, PhD, APN-BC; Christen Kutz, PhD, PA-C; Patricia Melville, RN, MSN, NP-C, MSCN; and Bryan Walker, MHS, PA-C.

2: Bruce Cree, MD, PhD, on the Historically Fast Progress Made in NMOSD Care

The clinical research director of the UCSF Multiple Sclerosis Center shared his perspective on the history of clinical care for neuromyelitis optica spectrum disorder in light of 3 recent FDA approvals of inebilizumab (Uplizna; Viela Bio), satralizumab (Enspryng; Genentech), and eculizumab (Soliris; Alexion).

3: NeuroVoices: Shazam Hussain, MD, FRCP, FAHA, on Ultra-Early IV tPA to Treat Emergent LVO

The director of the Cerebrovascular Center at Cleveland Clinic provided context on why stroke systems should incorporate intravenous tissue plasminogen activator, known as tPA, as early as possible to treat emergent large vessel occlusion—with ideal administration occurring in the "golden hour."

4: Highlights of AASM Guideline for Treatment of Central Disorders of Hypersomnolence

Coauthor of the guideline and member of the American Academy of Sleep Medicine board of directors, Lynn Marie Trotti, MD, MSc, discussed key takeaways from the new hypersomnolence guideline, which encompasses the first updates since 2007.

5: Podcast: Small Victories: Advancing Care in Parkinson Disease

Episode 45 of "Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Adolfo Ramirez-Zamora, MD, about the current state of care for patients with advanced Parkinson disease, the ongoing clinical development of therapies, remaining challenges to address in the clinic, and where the field is headed.

The 3rd Annual International Congress on the Future of Neurology® is coming up! The virtual meeting, which will showcase the most recent advancements in neurologic disorders, is being held September 17-18, 2021. The target audience for this activity is physicians who treat patients with neurologic disorders. Fellows, nurses, nurse practitioners, physician assistants, and other health care professionals interested in the management of patients with neurologic disorders are also invited to participate.

The learning objectives of the program are:

• Outline current and emerging diagnostic concepts for neurologic disorders
• Explain clinical evidence for the management of neurologic disorders across multiple lines of care
• Summarize the mechanism of action of therapeutic agents used to manage neurologic disorders
• Prepare strategies for early recognition and management of treatment-related toxicities associated with neurologic therapies
• Apply multidisciplinary care strategies for optimizing patient outcomes in the setting of neurologic disorders
• Assess recent landmark data from clinical trials in the context of evolving treatment paradigms in neurology